Abstract: Staphylococcus sciuri is a rare pathogen in humans, but it can cause a wide array of human infections. Recently a strain of S. sciuri (HBXX06) carrying exfoliative toxin C (ExhC) was reported to cause fatal exudative epidermitis in piglets and might be considered as a potential zoonotic agent. However, little is known regarding the pathogenicity of this bacterium. In this study, we predicted the three-dimensional structure of S. sciuri HBXX06 ExhC and replaced Ser231 or His107 or Asp156 in the active site of ExhC by site-directed mutagenesis, and examined the effects of mutant ExhC on BHK-21 cells and newborn mice as models. Interestingly, we found that mutant ExhC lost its exfoliative effects on newborn mice but could still induce necrosis in cultured cells if any one of the three amino acid residues in the active site was replaced. These results suggest that Ser231, His107 and Asp156 of ExhC play a critical role in the induction of skin exfoliation in neonate mice, which may help to further understand the mechanisms underlying the actions of exfoliative toxins.
Introduction
Exudative epidermitis (EE) in pigs results from infection with exfoliative toxin-producing strains of Staphylococcus hyicus (Andresen et al. 1993) and Staphylococcus sciuri (Chen et al. 2007) . EE is characterized by exfoliated epidermis accompanied by extensive exudation and crust formation. In addition to S. sciuri and S. hyicus, Staphylococcus chromogenes could also cause characteristic skin lesions of EE under laboratory conditions . Currently, at least six exfoliative toxins, ExhA-D, ShetA and ShetB, have been identified (Andresen 1998 (Andresen , 2005 Sato et al. 2000) , and the existence of these toxins seems to be speciesspecific (Takeuchi et al. 1987 ). These toxins have been characterized as proteins of approximately 27 kDa or 30 kDa (Andresen et al. 1993; Andresen 2005) . Staphylococcal scalded skin syndrome in humans is caused by Staphylococcus aureus strains that produce exfoliative toxin ETA and ETB, or both, and shares similar clinical signs and histopathology with EE in pigs, exhibiting blister formation and exfoliation of the skin due to the splitting of the skin at the granular layer of the epidermis (Sato et al. 1991; Andresen et al. 1993; Tanabe et al. 1996) . This similarity suggests that EE in animals may serve as a model for the studies of staphylococcal scalded skin syndrome in humans.
To explore the pathogenicity of S. sciuri strain HBXX06, we predicted the three-dimensional structure of ExhC, the only exfoliative toxin produced by S. sciuri HBXX06 (Chen et al. 2007) , obtained the mutant ExhC by replacing Ser231 or His107 or Asp156 in the active site of ExhC, and examined the activity of mutant ExhC using BHK-21 cells and newborn mice as models. We found that mutant ExhC lost its exfoliative effects on newborn mice but could still induce necrosis in cultured cells if any one of amino acid residues in the active site was replaced. These results suggest that Ser231, His107 and Asp156 of ExhC play a critical role in the induction of skin exfoliation in neonate mice. -R  GCGGCCGCTTTAATTAATTGTTTGAGATCTCTAATGA  H107A-R  GCTTCTTTAGCGATAGCATGGTTAG  H107A-F  CTAACCATGCTATCGCTAAAGAAGC  D156G-R  TTATTACTGAAATACCAACACCTGTTCC  D156G-F  GGAACAGGTGTTGGTATTTCAGTAATAA  S231G-R  AAATACCAGATCCTCCATTTCCCGG  S231G-F CCGGGAAATGGAGGATCTGGTATTT a All primers were designed according to the S. sciuri ExhC DNA sequence (JF755400). The sequences in bold represent mutagenic sites. The underlined sequences represent restriction enzymes.
Material and methods

Mice
Eight-week-old inbred BALB/c mice were purchased from Vital River Lab Animal Technology Company (China). All mice were housed in our animal care facility with food and water ad libitum for at least 3 days before mating. Newborn mice (less than 24 h) were used to determine the activity of recombinant ExhC.
Ethics statement
All procedures were approved by the Animal Care and Use Committee of China Agricultural University (Approval IDs: XXMB-2007-03-01-1 and XXMBB-2007-03-15-1) and used in accordance with regulations and guidelines of this committee.
Vector, bacterial stains, cells and culture conditions pMD19-T simple vector (Takara) was used as a cloning vector, and pET28a(+) (Novagene) as an expression vector. pET28a-ExhC recombinant vector from our laboratory was used to transform Escherichia coli BL21 (DE3) for the expression of wild-type ExhC. E. coli DH5α was used for plasmid preparation, and E. coli BL21 (DE3) was used for protein expression and purification. Transformed E. coli DH5α cells were grown in Luria-Bertani (LB) medium containing 100 µg/mL ampicillin while transformed E. coli BL21 cells were grown in LB medium containing 50 µg/mL kanamycin at 37
• C. BHK-21 cells were grown at 37
• C with 5% CO2 in complete Dulbecco's modified Eagle medium (Gibco) supplemented with 10% fetal bovine serum (HyClone), 1% nonessential amino acids (Gibco) and 200 U/mL penicillin and streptomycin for the examination of mutant ExhC activity.
DNA manipulation
Plasmid DNA was prepared using TIANprep Mini Plasmid kit (Tiangen Biotech). Restriction enzymes and T4 DNA ligase were purchased from Takara (China). All enzymatic reactions were carried out according to the manufacturer's instructions. DNA sequencing was performed by SinoGenoMax (China).
Site-directed mutagenesis by PCR To obtain ExhC mutants, pairs of complementary mutagenic primers (Table 1) were synthesized to prepare His107Ala, Asp156Gly or Ser231Gly. The single-amino acid mutant ExhC was named H107A or D156G or S231G, respectively, and the triple mutant ExhC was named HDS. The plasmid pET28a-ExhC carrying S. sciuri ExhC was used as a template for site-directed mutagenesis by a PCRbased method (Juncosa et al. 1994) including three separate steps. The first step was to use forward universal primer (ExhC-F) and the mutagenic primers to yield 5' end of single mutation, the second step was to employ complementary mutagenic primers and the reverse universal primer (ExhC-R) to yield 3' end of single mutation, and the third step was to use the products of 5' and 3' end of single mutations as templates and the universal primers to yield the whole ExhC gene with the targeted single amino acid mutation. The 5' end of HDS was amplified using ExhC-F and D156G-R as primers and pMD-H107A vector (as described below) as a template, and the 3' end of HDS was amplified using D156G-F and ExhC-R as primers and pMD-S231G vector (as described below) as a template. The whole triple mutation was amplified using the 5' and 3' end of HDS as templates and the universal primers. For these purposes, Fast PFU (Transgen) was used in the first and the second step and LA Taq (Takara) in the third step, which had a 3'→5' proofreading activity, and the best results could be obtained. The final amplified DNA was ligated to a pMD19-T simple vector, and the resulting plasmids (pMD-H107A, pMD-D156G, pMD-S231G and pMD-HDS) were transformed into E. coli DH5α. Transformants were grown on LB agar plates with ampicillin (100 µg/mL) at 37
• C and the colonies were screened by PCR and DNA sequencing analysis. The pMD-H107A, pMD-D156G, pMD-S231G, pMD-HDS and pET28a(+) were digested with Nco I and NotI, respectively. The linearized mutant ExhC was ligated to linearized pET28a(+), and the resulting plasmids (pET28a-H107A, pET28a-D156G, pET28a-S231G and pET28a-HDS) were sequenced.
Protein expression, purification of wild-type and mutant ExhC E. coli BL21 (DE3) competent cells were transformed with pET28a-ExhC or pET28a-H107A or pET28a-D156G or pET28a-S231G or pET28a-HDS. The positive colony was selected and grown in LB medium with kanamycin (50 µg/mL) overnight at 37
• C. When the culture density (OD600) reached 0.5-0.6, the culture was induced with 0.5 mM isopropyl-β-D-thiogalactopyranoside for 12 h at 16
• C before the cells were harvested. Bacterial cells were homogenized by sonication in a buffer (NPI-10, 50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0). The lysates were centrifuged at 18,000×g for 30 min at 4
• C. The supernatant containing recombinant proteins were purified on a nickelnitrilotriacetic acid agarose (Ni-NTA) column (Qiagen) under native conditions according to manufacturer's instructions and analyzed by 12% SDS-PAGE according to standard protocols (Higgins et al. 2010 ). The protein solution was dialyzed exhaustively against 1× phosphate-buffered saline (PBS, pH 7.4) for subsequent experiments. The final protein solution was concentrated by ultrafiltration (10-kDa cutoff, Millipore) and the concentration was determined by a Biophotometer (Eppendorf North America).
Western blot analysis
The lysates of transformed E. coli BL21 (DE3) were fractionated by 12% SDS-PAGE before transferred onto nitrocellulose membranes (Millipore). Blots were probed with anti-his (C-term) monoclonal antibody (diluted 1:2,000) (Invitrogen) or rabbit polyclonal antibodies against S. sciuri (diluted 1:5,000) (prepared in our laboratory). The blots were subsequently incubated with HRP-labelled goat antimouse IgG (diluted 1:10,000) or HRP-labelled goat antirabbit IgG secondary antibodies (diluted 1:10,000) (DingGuo Biotech). The blots were developed using chemiluminescence blot detection reagent (Vigorous Biotech).
Induction of lesions in newborn mice by ExhC
Groups of newborn mice (n = 9) were injected subcutaneously with recombinant wild-type ExhC at a dose of 500, 200 or 100 µg per mouse and returned to lactating mothers after treatment. Macroscopical skin lesions were recorded afterwards. Skin lesions were scored as follows: 100% stands for a lesion area greater than 1 cm 2 ; 75% for the lesion area between 0.5 and 1 cm 2 ; 50% for the lesion area between 0.25 and 0.5 cm 2 ; 25% for the lesion area less than 0.25 cm 2 and 0 for no lesion.
Examination of ExhC and its derivatives activity BHK-21 cells (2 × 10
4 ) were cultured on 96-well culture plates (Corning) for 12 h and treated with wild-type or mutant ExhC at a final concentration of 500 µg/mL or PBS as controls. The morphological changes of treated cells were observed under a microscope. The in vivo activities of ExhC and its derivatives were examined by treatment of newborn mice with 500 µg of purified proteins via subcutaneous injection. Gross lesions in the skin were examined every hour post treatment with ExhC and its derivatives. Tissues were collected for histological examination (Lamhamedi-Cherradi et al. 2003) .
Statistical analysis
The significance of the differences between treatment group and controls in lesion scores was determined by ANOVA.
Results
Cloning, expression and purification of mutant ExhC
ExhC was the only exfoliative toxin harboured in S. sciuri HBXX06 responsible for EE in piglets (Chen et al. 2007 ). To investigate the role of ExhC in the pathogenesis of EE, we predicted three-dimensional structure of ExhC using SWISS-MODEL (http://swissmodel. expasy.org/) (Kiefer et al. 2009) (Fig. 1) and found that ExhC active site consists of His107, Asp156 and Ser231. To determine the role of the three amino acid residues in the pathogenesis of ExhC, single and triple active-site mutants of ExhC was made as described in Materials and methods. Sequence analysis indicated that four ExhC derivatives (namely H107A, D156G, S231G and HDS) were obtained. As shown in Figure 2A , all the mutant ExhC proteins containing a His-tag at the C terminus could be Lane 1 was loaded with cell extracts of empty vector, lanes 2 and 3 with H107A before and after purification, lanes 4 and 5 with D156G before and after purification, and lanes 6 and 7 with S231G before and after purification.
expressed with E. coli expression system as examined by Western blot using anti-his monoclonal antibody and rabbit anti-S. sciuri serum. All the mutant ExhC proteins were purified using Ni-NTA column before subjected to SDS-PAGE analysis. As shown in Figure 2B , purified proteins were the only detectable band on SDS-PAGE, indicating that all mutant ExhC proteins were successfully expressed and purified.
Mutant ExhC proteins are capable of inducing necrosis in BHK-21 cells
In our previous study, we found that recombinant ExhC caused necrosis in BHK-21 cells (Li et al. 2011 ), thus we use BHK-21 as a model to examine the effects of mutant ExhC on cultured cells. We found that treatment of BHK-21 cells with both mutant ExhC and wild-type ExhC could cause cell death, whereas cells in the controls grew well (Fig. 3 ). These data demonstrate that mutant ExhC proteins are capable of inducing necrosis in BHK-21 cells, and that the change of any one amino acid in the active site of ExhC does not alter the necrosis-inducing feature of ExhC.
Amino acids Ser231, His107 and Asp156 of S. sciuri ExhC play a critical role in the induction of skin exfoliations in newborn mice Newborn mice were used as a conventional experimental model for skin lesions caused by ExhC (Fudaba et al. 2005) . We found that the severity of skin lesions was dependent on the dose of wild-type ExhC (Fig. 4A) . Ten hours after injection with ExhC at a dose of 500 µg/mouse, mice were succumbed to death. However, mice injected with ExhC at a dose of 200 µg/mouse displayed skin lesions, such as skin blistering and exfoliation around ExhC-injection sites (Fig. 4B ). In contrast, the control mice treated with PBS did not have any visible clinical signs (Fig. 4C) . If mice were injected with ExhC at a dose of 100 µg/mouse, there were no visible skin lesions. These data indicate that the purified ExhC proteins are toxic to animals at a certain dose. To further test the biological activities of the mutant ExhC proteins, newborn mice were injected subcutaneously with 500 µg of purified H107A, D156G, S231G, HDS and wild-type ExhC or with PBS as controls. Blistering and exfoliation of the skin occurred 6 h post ExhC treatment, whereas no clinical signs were observed in all mutant ExhC-treatment groups and the controls (Fig. 5A-F) . Histological examination of skin tissues from newborn mice revealed that wild-type ExhC-treated mice had severe skin lesions displaying exfoliated epidermis and necrosis in the dermis, while all the mutant ExhC-treatment groups and the control looked normal (Fig. 5G-L) . Together, these data demonstrate that mutant ExhC proteins lose the feature of causing skin exfoliation in newborn mice, and that His107, Asp156 or Ser231 plays an important role in the induction of skin lesions in newborn mice.
Discussion
S. sciuri is widely distributed in nature, and strains can easily be isolated from a variety of animals and products of animal origin (Couto et al. 1996; Stepanovic et al. 2001a ) as well as from human (Couto et al. 2000; Stepanovic et al. 2001b) . These bacteria are normally non-pathogenic to animals. However they could cause severe infections in humans (Hedin & Widerstrom 1998; Wallet et al., 2000; Horii et al. 2001; Stepanovic et al. 2003 Stepanovic et al. , 2005 . Currently very little is known regarding the pathogenicity of S. sciuri in animals. It has been reported that some pathogenic strains of S. sciuri are responsible for mastitis in ruminants such as goats (Poutrel 1984) and cows (Rahman et al. 2005) , suggesting that some members of S. sciuri are potentially pathogenic. In our previous study, we reported that a strain S. sciuri HBXX06 with ExhC as a major toxin was highly pathogenic to piglets (Chen et al. 2007) .
Exfoliative toxins are critical virulence factors for causing EE in pigs. From S. hyicus, a commonly seen causative agent for EE, four exfoliative toxins (ExhA-D) have been characterized (Ahrens & Andresen 2004) . Although certain strain of S. hyicus code for more than one exfoliative toxins (Andresen 2005) , ExhC is the only exfoliative toxin encoded by S. sciuri HBXX06 strain (Chen et al. 2007 ). In our previous study, we found that the ExhC (GenBank accession No. JF755400) from S. sciuri HBXX06 is identical to that of S. hyicus in GenBank (AF515455), and that recombinant ExhC expressed in E. coli BL21 cause necrosis in BHK-21 cells and skin lesions in newborn mice (Li et al. 2011) . In this study, we predicted the three-dimensional structure of S. sciuri HBXX06 ExhC and replaced Ser231, His107, Asp156 of ExhC, and found that mutant ExhC would lose the activity of inducing skin lesions in newborn mice if any one of those amino acid residues in the active site was changed.
Exfoliative toxin ETA and ETB were produced by S. aureus. It was reported that ExhA, ExhB, ExhC, ExhD, ETA and ETB show a certain similarity, exhibiting preservation of the catalytic tract of the active sites of the toxins (Ahrens & Andresen 2004 ). Evidence for a homologous relationship is that the catalytic triad His72, Asp120 and Ser195 of ETA align respectively with His65, Asp114 and Ser186 of ETB (Bailey & Redpath 1992) . In ExhA-ExhC, His115, Asp164 and Ser239 are considered to be the catalytic triad, although the Asp164 in ExhD is replaced with a glutamate (Ahrens & Andresen 2004) . In this study, we found that Ser231, His107 and Asp156 formed the active site of ExhC, which supports the previous report (Ahrens & Andresen 2004) . It was reported that mutant ETA, containing amino acid substitutions at any one of amino acid residues in the catalytic triad, are not active as exfoliations in the animal model of staphylococcal scalded skin syndrome (Papageorgiou et al. 2000) . We replaced Ser231, His107 and Asp156 of ExhC by sitedirected mutagenesis based on the predicted active site of ExhC, and found that newborn mice subcutaneously injected with mutant ExhC containing amino acid substitutions at any one of amino acid residues in active sites, displayed no blister formation and skin exfoliation. Interestingly, all mutant ExhC retain the activity of inducing necrosis in BHK-21 cells. These results suggest that the similarity of catalytic triad exist between ETA and ExhC, and that the molecular mechanisms underlying ExhC-induced skin lesions in newborn mice and ExhC-induced necrosis in mammalian cells may be different.
In summary, the results from the present study demonstrate that amino acids Ser231, His107 and Asp156 constitute the catalytic triad of S. sciuri ExhC, and that each of them may play an important role in the pathogenicity of S. sciuri, which will provide some clues to elucidating the role of other exfoliative toxins of the genus Staphylococcus.
